Massachusetts Financial Services Co. MA Boosts Stock Position in Masimo Corporation $MASI

Key Points

• Massachusetts Financial Services Co. MA raised its stake by 1.7% to 2,663,875 shares, now owning approximately 4.96% of Masimo, valued at about $346.5 million.
• Analyst consensus is a Reduce rating with a consensus target price of $181.17 after several downgrades, with eight analysts at Hold and one at Sell.
• Masimo has a market cap of roughly $9.58 billion, a negative P/E (-16.92), and its share price (~$178) is trading near its 12‑month high of $179.00.

Massachusetts Financial Services Co. MA raised its stake in shares of Masimo Corporation (NASDAQ:MASI - Free Report) by 1.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,663,875 shares of the medical equipment provider's stock after acquiring an additional 43,915 shares during the period. Massachusetts Financial Services Co. MA owned approximately 4.96% of Masimo worth $346,464,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC raised its stake in Masimo by 80.0% during the 3rd quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider's stock valued at $44,000 after acquiring an additional 136 shares during the last quarter. Advisory Services Network LLC purchased a new stake in Masimo during the 3rd quarter valued at approximately $46,000. Danske Bank A S purchased a new stake in Masimo during the 3rd quarter valued at approximately $59,000. Clearstead Advisors LLC raised its stake in Masimo by 18.4% during the 3rd quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider's stock valued at $69,000 after acquiring an additional 73 shares during the last quarter. Finally, Quantbot Technologies LP purchased a new stake in Masimo during the 2nd quarter valued at approximately $86,000. 85.96% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have commented on MASI. Stifel Nicolaus set a $180.00 price objective on Masimo in a research note on Tuesday, February 17th. Weiss Ratings reissued a "sell (d)" rating on shares of Masimo in a research note on Thursday, January 22nd. Wolfe Research downgraded Masimo from a "strong-buy" rating to a "hold" rating in a research note on Thursday, February 19th. Raymond James Financial downgraded Masimo from an "outperform" rating to a "market perform" rating in a research note on Friday, March 27th. Finally, Wells Fargo & Company raised Masimo to a "hold" rating in a research note on Wednesday, March 18th. Eight research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of "Reduce" and a consensus target price of $181.17.

Masimo Stock Performance

Shares of MASI stock opened at $178.32 on Friday. The company has a market cap of $9.58 billion, a price-to-earnings ratio of -16.92, a price-to-earnings-growth ratio of 1.81 and a beta of 1.20. The stock has a 50 day simple moving average of $167.47 and a 200-day simple moving average of $150.75. Masimo Corporation has a 12-month low of $125.94 and a 12-month high of $179.00. The company has a current ratio of 2.49, a quick ratio of 1.47 and a debt-to-equity ratio of 0.72.

Masimo Company Profile

Masimo NASDAQ: MASI is a global medical technology company specializing in noninvasive monitoring solutions. The company's flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo's portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.